Antibodies News and Research

RSS

Scientists use Deep Learning to predict development of hematopoietic stem cells

Autonomous driving, automatic speech recognition, and the game Go: Deep Learning is generating more and more public awareness.

21 Feb 2017

Scientists engineer smallest CRISPR-Cas9 system to date

Scientists at the Center for Genome Engineering, within the Institute for Basic Science0, in collaboration with KIM Eunji and KIM Jeong Hun have engineered the smallest CRISPR-Cas9 to date, delivered it to the muscle cells and in the eyes of mice via adeno-associated viruses and used it to modify a gene causing blindness.

21 Feb 2017

Penn researchers find new way to track rare T cells in blood after annual flu vaccine

For most vaccines to work the body needs two cell types - B cells and T helper cells - to make antibodies. B cells are the antibody factories and the T helper cells refine the strength and accuracy of antibodies to home and attack their targets.

20 Feb 2017

New approach could make organometallic catalysis applicable for therapy or diagnostics

A gold catalyst can be delivered to a target organ in a higher organism where it performs a chemical transformation visualized by bioimaging.

17 Feb 2017

Research provides more evidence that mRNA vaccines can protect mice against Zika virus

Vaccine developers have successfully protected mice against Zika by injecting synthetic messenger RNA that encodes for virus proteins into the animals.

17 Feb 2017

DNA computer could be important step towards development of smart, 'intelligent' drugs

Researchers at Eindhoven University of Technology present a new method that should enable controlled drug delivery into the bloodstream using DNA computers.

17 Feb 2017

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

Researchers of the Cancer Virotherapy Research Group of Bellvitge Biomedicine Research Institute, led by Dr. Ramon Alemany, have developed an oncolytic virus capable of redirecting the patient's immune system against their tumor cells.

16 Feb 2017

Salk scientists use mRNA to successfully treat hemophilia B in mice

FedEx, UPS, DHL--when it comes to sending packages, choices abound. But the most important delivery service you may not have heard of mRNA.

16 Feb 2017

Combination of drugs amplifies kill rates of brain cancer tumours in mice

A promising combination of immunotherapies delivers a one-two punch to brain cancer tumours with high cure rates in mice, scientific evidence published in Nature Communications today says.

15 Feb 2017

Only subset of mother's HIV virus infects infants during pregnancy or breastfeeding, research shows

In the transmission of HIV-1 from mother to child only a subset of a mother's viruses infects their infants either in utero or via breastfeeding, and the viruses that are transmitted depend on whether transmission occurs during pregnancy or through breastfeeding, according to UCLA-led research.

15 Feb 2017

Research opens treatment pathways for cancers that do not respond to targeted antibodies

By hijacking a cancer cell's own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not responsive to conventional targeted antibodies, such as triple-negative breast cancer.

15 Feb 2017

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

A pair of scientists from the Florida campus of The Scripps Research Institute have been awarded up to $3.3 million from the National Cancer Institute of the National Institutes of Health to create the next generation of breast cancer treatments for the thousands of patients whose current treatment options are limited.

14 Feb 2017

Plant-based drug for hemophilia shows promise in animal models

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

13 Feb 2017

Researchers develop new antiviral strategy to combat respiratory syncytial virus

Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children.

13 Feb 2017

Researchers identify molecular signatures to predict efficacy of malaria vaccines

The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.

13 Feb 2017

Researchers use liquid biopsies, tiny experimental device to predict cancer spread and hasten diagnosis

A team of investigators from Cedars-Sinai and UCLA is using a new blood-analysis technique and tiny experimental device to help physicians predict which cancers are likely to spread by identifying and characterizing tumor cells circulating through the blood.

13 Feb 2017

URMC researchers discover how omega 3 fatty acids in fish oil could be used for asthma patients

University of Rochester Medical Center scientists have discovered new essential information about omega 3 fatty acids contained in fish oil and how they could be used for asthma patients.

9 Feb 2017

Researchers identify E. coli bacteria linking Crohn's disease to spondyloarthritis

Patients with Crohn's disease, a type of inflammatory bowel disease (IBD) that causes abdominal pain and diarrhea, can also experience joint pain.

9 Feb 2017

Exosome isolation using ultracentrifugation

In the outpatient clinic and lab, our research studies aim to understand biological functions of exosomes and membrane particles.

From Beckman Coulter Life Sciences - Centrifugation 9 Feb 2017

New antibody drug shows promising results to prevent or treat HIV

A new biologic agent--the most potent of its kind so far--is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.

7 Feb 2017

Antibodies News and Research

Scientists use Deep Learning to predict development of hematopoietic stem cells

Scientists engineer smallest CRISPR-Cas9 system to date

Penn researchers find new way to track rare T cells in blood after annual flu vaccine

New approach could make organometallic catalysis applicable for therapy or diagnostics

Research provides more evidence that mRNA vaccines can protect mice against Zika virus

DNA computer could be important step towards development of smart, 'intelligent' drugs

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

Salk scientists use mRNA to successfully treat hemophilia B in mice

Combination of drugs amplifies kill rates of brain cancer tumours in mice

Only subset of mother's HIV virus infects infants during pregnancy or breastfeeding, research shows

Research opens treatment pathways for cancers that do not respond to targeted antibodies

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

Plant-based drug for hemophilia shows promise in animal models

Researchers develop new antiviral strategy to combat respiratory syncytial virus

Researchers identify molecular signatures to predict efficacy of malaria vaccines

Researchers use liquid biopsies, tiny experimental device to predict cancer spread and hasten diagnosis

URMC researchers discover how omega 3 fatty acids in fish oil could be used for asthma patients

Researchers identify E. coli bacteria linking Crohn's disease to spondyloarthritis

Exosome isolation using ultracentrifugation

New antibody drug shows promising results to prevent or treat HIV

Immunology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News